Loading
Life sciences · Journal article
Cancer Reports · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
BACKGROUND: Despite significant advances in breast cancer therapy, resistance to apoptosis remains a major obstacle to successful treatment. Lifeguard (LFG), an antiapoptotic membrane protein, has been implicated in breast cancer progression; however, its role in endoplasmic reticulum (ER) stress-associated molecular responses and apoptosis-related gene regulation remains incompletely understood. AIMS: This study aimed to investigate molecular changes associated with LFG-targeted siRNA treatment and reduced LFG mRNA expression in human breast cancer cells. METHODS AND RESULTS: Profiler PCR Array, and intracellular calcium-associated fluorescence was assessed by fluorescence-based calcium imaging. LFG mRNA expression was markedly reduced following LFG-specific siRNA treatment in MDA-MB-231 cells, whereas a more moderate reduction was observed in MCF10A cells. LFG-targeted siRNA treatment was associated with altered intracellular calcium-associated fluorescence and differential expression of several ER stress- and apoptosis-related genes, including upregulation of CREB3L3, SREBF1, and INHBE, as well as downregulation of EDEM1, HSPA2, and RRM2. CONCLUSIONS: These findings demonstrate that LFG-targeted siRNA treatment and reduced LFG mRNA expression are associated with changes in intracellular calcium-related responses and ER stress- and apoptosis-associated gene expression, particularly in MDA-MB-231 cells. Further studies are required to determine the underlying mechanisms and establish the functional role of LFG in these cellular responses.